地址:江苏省无锡市梁溪区锡沪东路8号301-2 电话:0510-82732223 / 86-0510-82732223 邮箱:info@dldevelop.com.cn
备案号:苏ICP备06050612号-1 苏公网安备 32020302000048号 版权所有 @2016 无锡市东林科技发展有限责任公司Language:English
Product name: | ER780 Anti-Human CD197/CCR7 Antibody |
Catalog: | DL22938F |
Synonyms : | CMKBR7, EBI1, EVI1,CCR-7,CDw197 |
Reactivity: | Human |
Applications: | FCM |
Size: | 20Tests |
Host: | Mouse |
Clonality: | |
Background: | CCR7, also known as CD197, is a chemokine receptor that binds CCL19 and CCL21. CCR7 and its ligands link innate and adaptive immunity by affecting interactions between T cells and dendritic cells and their downstream effect. Naïve T cells enter the lymph node through high endothelial venules, which express CCL21. Dendritic cells and macrophages enter the lymph node through afferent lymphatics. The encounter of T cells and dendritic cells in the T cell zone is CCR7-dependent. In addition, during immunological surveillance, B cells recirculate between B-cell-rich compartments (follicles or B cell zones) in secondary lymphoid organs, surveying for antigen. After antigen binding, B cells move to the boundary of B and T zones to interact with T-helper cells; this B cell migration is directed by CCR7 and its ligands. CCR7-positive cancer cell expression has been associated with lymph node metastasis. Product Details |
Concentration: | |
Immunogen: | |
Purification_Method: | |
Buffer: | PBS with 0.05% Proclin300, 1% BSA |
Dilution: | |
Gene ID(Human): | 1236 |
Storage: | Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. |